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Abstract—Elevated arterial pulse pressure and blood pressure (BP) can lead to atrophy of cerebral white matter (WM),
potentially attributable to shared genetic factors. We calculated the magnitude of shared genetic variance between BP
and fractional anisotropy of water diffusion, a sensitive measurement of WM integrity in a well-characterized population
of Mexican Americans. The patterns of whole-brain and regional genetic overlap between BP and fractional anisotropy
were interpreted in the context the pulse-wave encephalopathy theory. We also tested whether regional pattern in genetic
pleiotropy is modulated by the phylogeny of WM development. BP and high-resolution (1.71.73 mm; 55 directions)
diffusion tensor imaging data were analyzed for 332 (202 females; mean age 47.913.3 years) members of the San Antonio
Family Heart Study. Bivariate genetic correlation analysis was used to calculate the genetic overlap between several BP
measurements (pulse pressure, systolic BP, and diastolic BP) and fractional anisotropy (whole-brain and regional values).
Intersubject variance in pulse pressure and systolic BP exhibited a significant genetic overlap with variance in whole-brain
fractional anisotropy values, sharing 36% and 22% of genetic variance, respectively. Regionally, shared genetic variance was
significantly influenced by rates of WM development (r0.75; P0.01). The pattern of genetic overlap between BP and
WM integrity was generally in agreement with the pulse-wave encephalopathy theory. Our study provides evidence that a set
of pleiotropically acting genetic factors jointly influence phenotypic variation in BP and WM integrity. The magnitude of this
overlap appears to be influenced by phylogeny of WM development, suggesting a possible role for genotype-by-age
interactions. (Hypertension. 2011;57:330-335.) ● Online Data Supplement
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Elevated blood pressure (BP) is a well-known risk factorfor atrophy of cerebral white matter (WM), and this can
lead to cognitive decline and disability in the elderly.1 BP and
the integrity of cerebral WM are under strong genetic control,
with up to 80% of individual variance explained by genetic
factors.2–8 We hypothesized that the genetic factors respon-
sible for elevation in BP were also responsible for decline in
WM integrity. This hypothesis was tested in a well-
characterized population of Mexican Americans randomly
selected from large extended families.9 WM integrity was
gauged as fractional anisotropy (FA) using diffusion tensor
imaging (DTI), a fully quantitative technique that is capable
of ascertaining subtle decline in WM integrity.10
First, we investigated whether shared genetic variance
between BP and FA measurements was consistent with the
pulse-wave encephalopathy (PWE) theory, as suggested pre-
viously.5,6 PWE posits the direct and indirect biological
effects to explain the regional pattern of BP-related decline in
the integrity of cerebral WM.11–13 The direct PWE effect
suggests that an increase in arterial pulse pressure (PP) can
lead to gliosis of periventricular WM resulting from mechan-
ical damages associated with increased amplitude of cerebro-
spinal fluid movement.5 The indirect PWE effect suggests
that an increase in systolic BP (SBP) can lead to focal gliosis
in subcortical WM because of stenosis and loss of permeabil-
ity of small cerebral blood vessels.13,14 Next, we investigated
whether shared genetic variance between BP and FA was
influenced by a difference in WM development rates.15
Previous studies suggested a connection between the rates of
cerebral development and the genetic contribution to the
variance of several brain structures.16,17 Development of WM
tracts associated with higher cognitive function follow a more
protracted trajectory, with larger FA increases per year than
sensory and motor tracts.15 We therefore investigated
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whether WM tracts that exhibit high maturation rates
would be more susceptible to detrimental effects of ele-
vated BP and would therefore show more genetic overlap
with the BP measurements.
Methods
Subjects and Measurements
Analyses were performed in 332 (202 females) active participants in
the San Antonio Family Heart Study (SAFHS)9 for whom DTI and
BP measurements were available. Participants in the SAFHS study
are urban-dwelling Mexican Americans from large extended pedi-
grees selected randomly from the community. These subjects are
characterized by a relatively adverse cardiovascular risk profile,
including increased rates of obesity, dyslipidemia, glucose intoler-
ance, and hyperinsulinemia, compared with non-Hispanic whites in
San Antonio.9 Subjects ranged in age from 19 to 79 years
(47.913.3 years) and were part of 45 families (9.28.1 individuals
per family; range 2 to 35). Among the 400 subjects recruited for this
study, 39 were excluded from MRI for MRI contraindications
(n31), history of neurological illnesses (n5), or stroke, transient
ischemic attack, or other major neurological event (n3). DTI data
were not collected for 29 subjects because a subject was unable to
complete the MRI session (n22), scanner malfunction (n4), and
other reasons (n3). At the time of collection of BP measurements,
117 subjects (35%; 72 females; average age 54.813.0 years) were
diagnosed with hypertension, including 44 subjects (31 female;
average age 58.712.2 years) who were observed to be taking
antihypertensive medications (all antihypertension drugs were di-
rectly visually verified and recorded). There was no evidence for
hypotension in this cohort, with none of the individuals exhibiting
BPs with an SBP of 90 mm Hg and/or diastolic BP (DBP)
60 mm Hg. In addition,133 subjects were obese (body mass index
30), 96 subjects had elevated cholesterol levels (total cholesterol
levels 200 mg/dL), 22 subjects had elevated blood lipids (150
mg/dL), 63 subjects were reported to have type 2 diabetes, and 12
subjects were reported to have coronary heart disorders (supplemen-
tal Table I, available online at http://hyper.ahajournals.org). Alcohol
and depression disorders were not exclusion criteria, with 26 subjects
reporting alcohol dependence and 99 subjects reporting a lifetime
major depressive episode (supplemental Table I). All subjects
provided written informed consent on forms approved by the
institutional review board of the University of Texas Health Science
Center at San Antonio.
BP Measurements
Collection of SBP and DBP measurements was detailed in Ruther-
ford et al2 and proceed the imaging by an average of 3.00.8
(maximum 5.3) years. In short, SBP and DBP measurements were
performed using a random-zero sphygmomanometer on the left arm.
Three measurements were performed with 5-minute intervals, and
the average of the last 2 measurements was used as trait value. PP
was calculated as the difference between SBP and DBP. The average
SD SBP, DBP, and PP values were 122.616.6, 71.310.8, and
51.314.2, respectively.2
DTI and Processing
DTI was performed at the Research Imaging Institute, University of
Texas Health Science Center at San Antonio, on a Siemens 3T Trio
scanner. A single-shot, single refocusing spin-echo, echo-planar
imaging sequence was used to acquire diffusion-weighted data, with
a spatial resolution of 1.71.73.0 mm. The sequence parameters
were echo time/repetition time87/8000 ms; field of view200 mm; 55
isotropically distributed diffusion-weighted directions; 2 diffusion-
weighted values; b0 and 700 s/mm2 and 3 b0 (nondiffusion-
weighted) images. These parameters were calculated using an
optimization technique that maximizes the contrast to noise ratio for
FA measurements.18
Details for the processing of DTI scans have been discussed
previously.3,19,20 In short, the tract-based spatial statistics software21
was used for multisubject analysis of FA images. FA images were
created by fitting the diffusion tensor to the raw diffusion data.22 All
FA images were nonlinearly aligned to a group-wise, minimal-
deformation target brain.23 Next, individual FA images were aver-
aged to produce a group-average anisotropy image. This image is
used to create a group-wise skeleton of WM tracts that encodes the
medial trajectory of the WM fiber tracts. Finally, FA values from
each image were projected onto the group-wise skeleton of WM
structures. This step accounts for residual misalignment among
individual WM tracts. FA values are assigned to each point along a
skeleton using the peak value found within a 20-mm distance
perpendicular to the skeleton. The FA values vary rapidly perpen-
dicular to the tract direction but very slowly along the tract direction.
By assigning the peak value to the skeleton, this procedure effec-
tively maps the center of individual WM tracts on the skeleton.
The whole-brain (WB) average FA value for each subject was
calculated as the average FA value for the entire WM skeleton of
300103 voxels. Next, the tract-wise average FA measurements
were calculated for 10 major WM tracts (Table 1) as described in our
previous publications.3,20 In short, the population-based, 3D, DTI
cerebral WM tract atlas developed at Johns Hopkins University and
distributed with the FSL package21 was used to calculate population
average diffusion parameter values along the spatial course of the 10
largest (volume 5 cm3) WM tracts (Table 1). The Johns Hopkins
University atlas was nonlinearly aligned to the minimal-deformation
target brain, and image-containing labels for individual tracts were
transferred to minimal-deformation target space using nearest-
neighbor interpolation. Per-tract average values were calculated by
averaging the values along the tracts in both hemispheres.
Genetic Analyses
Two sets of analyses were performed to study the magnitude and
regional variations in shared genetic variance between the BP and
FA using bivariate genetic correlation analyses methods imple-
mented in the SOLAR software package. First, we analyzed the
magnitude of shared genetic effect between BP and WB average FA
(WB-FA) values. This was followed by calculation of regional
bivariate genetic correlations between BP and tract-wise regional FA
values. Beverage genetic analysis calculates the magnitude and
significance of genetic correlation coefficient (G), which is the
proportion of variability attributable to shared genetic effects. The
overall phenotypic correlation (P) between 2 traits A and B
(Equation) can be expressed using the correlation attributable to
shared additive genetic effects (G) and the residual correlation (E)
attributable to shared environmental effects:
PhA2hB2G1hA21hB2E,
Table 1. WM Tracts Used in the Analysis
Tract Fiber Type Connections
Genu of corpus callosum C Cerebral hemispheres




Cingulum A Cingulate gyrus/hippocampus
Corona radiata P Cortical/subcortical







Superior longitudinal fasciculus A Frontal/temporal/occipital
Sagittal stratum A/P Subcortical/temporal/occipital
C indicates commissural; P, projection; A, association.
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where h2A and h2B denote the additive genetic heritabilities for each
of the traits (ie, the proportion of the total phenotypic variance that
is explained by additive genetic factors). If the genetic correlation
coefficient (G) is significantly different from zero, then the signif-
icant portion of the variance in 2 traits are considered to be
influenced by shared genetic factors.24 All genetic analyses were
conducted with age, sex, agesex, age2 age2sex included as
covariates. The health screening data (supplemental Table I) were
not used as covariates because of the loss of statistical power to
detect genetic effects attributable to their potentially overlapping
genetic bases.24
Estimating Confounding Effects of the
Antihypertensive Treatment
Genetic analyses can potentially be confounded by the antihyperten-
sive treatment. We estimated the confounding effects of the antihy-
pertensive drugs using 2 approaches, as suggested by Cui et al.25
First, we used an exclusion approach in which the genetic correlation
analyses were performed in a cohort that excluded 44 subjects who
were taking antihypertensive medication at the time of BP collection
(supplemental Table I). Next, we used a phenotype adjustment
approach in which fixed values of 10 and 5 mm Hg were added to
the SBP and DBP values, respectively, for the 44 subjects who were
taking antihypertensive medication.25 The estimate of the magnitude
of the confounding effect was made based on the significance of the
difference in the genetic correlation coefficient among the measure-
ments made in the original versus adjusted cohorts.
Results
WB-FA values showed a significant negative linear trend
with both PP and SBP (r20.20 and 0.11, respectively;
P104), with no significant relationship observed between
WB-FA and SBP (supplemental Figure I). Quantitative ge-
netic analyses estimated that 50% of the intersubject
variance for the WB-FA, PP, and SBP and 17% of the
variance for the DBP were attributed to additive genetic
factors (Table 2). Age and age2 were significant covariates
for PP and WB-FA. Age was a sole significant covariate for
SBP. DBP did not have significant covariates. There were no
significant (P0.05) age by sex or age2 by sex interactions
detected.
Genetic correlation analyses between BP and the WB-FA
values reported that PP and SBP shared 36% (obtained from
squaring G) and 22% of genetic variance with the WB-FA
values, respectively (Table 3). The negative sign of these
correlation coefficients suggested that the same genetic fac-
tors associated with higher PP and SBP were linked to
progressively lower FA values. Genetic correlation between
WB-FA and DBP was not significant (Table 3). The estimates
of the confounding effects of the antihypertensive were
obtained by excluding 44 subjects who were taking antihy-
pertensive medications and by adding 10 and 5 mm Hg to the
SBP and DBP values for the treated subjects. There was no
significant difference in either sign or magnitude of genetic
correlations (Table 3). Therefore, all further regional analyses
were performed in the full pedigree, using the uncorrected BP
measurements.
Genetic correlation analyses between BP and the tract-wise
FA values (Table 4) indicated that 6 of 10 WM tracts (genu
of corpus callosum, body of corpus callosum, splenium of
corpus callosum, fronto-occipital, superior longitudinal fas-
ciculus, and sagittal stratum) showed a statistically significant
(P0.05) genetic correlation with PP. Genetic correlation
failed to reach statistical significance (0.05P0.10) for 3
more tracts: cingulum, corona radiata, and external capsule
(Table 4). Genetic correlation coefficients for FA of 4 tracts
(genu of corpus callosum, body of corpus callosum, fronto-
occipital, and sagittal stratum) showed a statistically signifi-
cant (P0.05) genetic correlation with SBP and approached
significance (P0.10) for splenium of corpus callosum (Ta-
ble 4). There were no significant or suggestive genetic
correlation coefficients observed for the genetic correlation
coefficients with DBP (Table 4).
The plot of the genetic correlation coefficients (G) for 10
WM tracts versus tract-wise rates of cerebral maturation20
(Figure) demonstrate that WM bundles with higher rates of
maturation shared a progressively higher genetic overlap with
both PP and SBP. Linear regression analysis reported that this
relationship was statistically significant for both PP and SBP
(Pearson r20.55 and 0.57; P0.01, respectively; Figure) but
not for DBP (Pearson r20.23; P0.16).
Discussion
This study in a large, well-characterized sample of Mexican
American participants in the SAFHS9 demonstrated that the
arterial PP and SBP shared 36% and 22% of genetic variance
with the WB FA of WM, respectively. In the past, the
integrity of cerebral WM was commonly assessed using the
T2-hyperintense WM (HWM) lesion imaging techniques.5–8
HWM lesions are the regions of accumulation of extracellular
water attributable to focal degradation of the myelin sheath,14
Table 2. Heritability of WB-FA and BP Indices
Trait h2 (P) Significant Covariates (P)
Variance Explained
by Covariates
WB-FA 0.52 (106) Age (1.5E-17), age2 (0.002) 31%
PP 0.53 (104) Age (1E-3), age2 (1E-4) 23%
SBP 0.63 (106) Age (1E-3) 11%
DBP 0.17 (0.04) None 0%
Table 3. Genetic Correlation Coefficients G (95% CI; P) Between WB-FA Values and 3
Measurements of Arterial BP: PP, SBP, and DBP
WB-FA PP (CI; P) SBP (CI; P) DBP (CI; P)
G (P) 0.60 (0.96,0.24; P10
3) 0.47 (0.81,0.13; P0.01) 0.10 (0.52, 0.72; P0.8)
G (P)* 0.62 (1.0,0.24; P10
3) 0.45 (0.81,0.09; P0.02) 0.12 (0.05, 0.74; P0.7)
G (P)† 0.64 (1.0,0.22; P10
3) 0.43 (0.79,0.07; P0.03) 0.08 (0.50, 0.64; P0.7)
*Calculated after the exclusion of 44 subjects taking antihypertensive medications.
†Calculated after the addition of 10 and 5 mm Hg to the SBP and DBP measurements for subjects taking
antihypertensive medications.
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and their volume is an important neuroimaging marker of
cerebral integrity.26 DTI has an advantage over HWM-
imaging techniques because it is capable of ascertaining
subtle WM damage that precedes formation of HWM le-
sions.10 Several recent studies confirmed that DTI is a
sensitive neuroimaging marker of WM integrity in hyperten-
sive individuals.10,27,28 Specifically, FA values were inversely
correlated with the arterial PP and SBP in both normotensive
and hypertensive individuals.27
The PP shared more genetic variance with the WB-FA
values than SBP. This is consistent with the PWE theory,12,13
which suggests that elevation in the arterial pulsativity can
lead to cerebral injury even in normotensive individuals.27
Similar pattern was observed in a previous whole-genome
linkage study in this population, in which PP and the volume
of HWM lesion shared significant genetic loci, whereas the
association between SBP and HWM lesion volume only
reached suggestive significance.5 The regional patterns of
Table 4. Heritability
WM Tract h2 (P)
Rate of
Maturation
(FA/Year)20 G (CI; P) PP G (CI; P) SBP G (CI; P) DBP
Genu of corpus callosum 0.66 (109) 21.3104 0.59 (0.90,0.30; 104) 0.55 (0.85,0.25; 103) 0.17 (1.0, 0.83; 50)
Body of corpus callosum 0.54 (107) 14.7104 0.44 (0.80,0.08; 0.01) 0.61 (0.97,0.08; 104) 0.32 (0.92, 0.28; 30)
Splenium of corpus
callosum
0.57 (107) 8.4104 0.43 (0.85,0.01; 0.04) 0.33 (0.71, 0.05; 0.10) 0.05 (1.0, 1.0; 0.87)
Cingulum 0.34 (103) 13.6104 0.39 (0.85, 0.07; 0.10) 0.18 (0.64, 0.28; 0.40) 0.37 (0.23, 0.97; 0.30)
Corona radiata 0.56 (107) 2.5104 0.33 (0.71, 0.05; 0.08) 0.19 (0.55, 0.17; 0.30) 0.23 (0.70, 1.0; 0.46)
External capsule 0.43 (105) 0.3104 0.25 (0.65, 0.15; 0.21) 0.19 (0.57, 0.19; 0.30) 0.21 (0.87, 1.0; 0.54)
Internal capsule (including
thalamic radiation)
0.43 (106) 4.7104 0.41 (0.93, 0.11; 0.09) 0.19 (0.63, 0.25; 0.40) 0.42 (0.14, 0.98; 0.28)
Frontal-occipital 0.41 (106) 10.9104 0.45 (0.85,0.05; 0.03) 0.43 (0.85,0.01; 0.05) 0.16 (1.0, 1.0; 0.65)
Superior longitudinal
fasciculus
0.58 (107) 6.8104 0.38 (0.76, 0.00; 0.04) 0.29 (0.67, 0.10; 0.20) 0.11 (1.0, 1.0; 0.72)
Sagittal stratum 0.40 (104) 12.4104 0.67 (1.0,0.29; 104) 0.51 (0.91,0.30; 0.01) 0.21 (0.90, 1.0; 0.54)
The rates of maturation and senescence20 and the genetic correlation coefficients G (95% CI; P) were calculated for 10 major WM tracts.
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Figure. The tract-wise genetic correlation coefficients (G) for PP (top graph) and SBP (bottom graph) are plotted versus tract-wise
rates of cerebral maturation (Table 4) in FA units per year taken from.20 Linear regression analyses (solid lines) indicated that the
by-tract variability in the magnitude of genetic overlap was significantly correlated with the by-tract rates of FA increase during matura-
tion for both PP and SBP (Pearson r0.74 and 0.76; P0.01).
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genetic overlap between BP and FA were in agreement with
the direct and indirect mechanisms of BP-related cerebral
injury as described by the PWE theory. The direct mechanism
is primarily responsible for the gliosis of the periventricular
WM.12,13 This explains the high negative (G0.43 to
0.67) genetic correlation between PP and periventricular
WM tracts. The highest genetic correlation was observed for
the sagittal stratum, which is located in the area that is
especially susceptible to the periventricular gliosis.27 The
indirect mechanism of the PWE theory is suggested to be
responsible for formation of subcortical WM lesions, most
commonly observed in the frontal lobe.11,27 This may explain
high genetic correlations observed between the SBP and the
FA of the genu and the body of CC because these tracts
contain commissural fibers connecting frontal lobes. The
biological pathway of the indirect mechanisms remains un-
clear. Stenosis of small cerebral vessels, especially in the
watershed areas,29 and high metabolic demands of oligoden-
drocytes of associative WM contribute to a high vulnerability
of the frontal WM to the indirect PWE mechanism.30 Oligo-
dendrocytes of the associative frontal WM are among the
most metabolically active cells in the adult central nervous
system and are therefore highly susceptible to damages from
hypoxia.30 In addition, the oligodendrocytes of the associated,
frontal WM tracts have reduced rates (per axonal-segment) of
myelin production and repair,31 and this is thought to be
responsible for the protracted age-related myelination and
sharp age-related decline.20
Previous findings suggested that the protracted develop-
ment and high metabolic demands of associative WM make it
more vulnerable to age-related neurodegeneration than sen-
sory and motor WM.19,27,32 In agreement with these findings,
our results showed that WM tracts that continue to myelinate
into adulthood, and therefore show higher age-related matu-
ration rates, shared progressively more genetic overlap with
PP and SBP. In fact, 50% of regional variability in shared
genetic variance was explained by the regional rates of
cerebral maturation. We interpret this finding as the evidence
for genotype-by-age interaction, with protracted development
of associative WM contributing to its higher susceptibility to
the neurodegeneration associated with elevated PP and SBP.
Unlike PP and SBP, significant genetic correlations were
not observed between DBP and FA. However, given the
lower observed heritability of DBP, the current study is
relatively underpowered and can therefore fail to identify
genetic correlations for this pair of phenotypes. The statistical
power of the current study may also have been limited to
detect significant genetic correlation for track-wise measure-
ments of FA, in which the magnitude of genetic correlation
coefficients for several analyses approached statistical signif-
icance. Therefore, the lack of significant genetic correlations
cannot be interpreted as evidence against the existence of
those pleiotropic relationships. In addition, our study exam-
ined Mexican Americans, a population with significant Na-
tive American admixture. If relatively rare variants are
involved in the determination of quantitative variance, we
may expect considerable differences in the degree of shared
genetic variance in other populations, such as European
Americans.33
Perspective
Our findings in a population characterized by an adverse
cardiovascular risk profile demonstrated that genetic factors
responsible for elevation in arterial PP and SBP were also
responsible for declining integrity of cerebral WM. In agree-
ment with PWE theory, the highest genetic association with
WM integrity was observed for PP. Further, our data dem-
onstrated that associative WM tracts that facilitate high-order
cognitive functioning showed higher vulnerability to the
elevated PP and SBP than motor and sensory WM tracts. The
statistical power of this study was not sufficient to localize
the individual genes responsible for the pleiotropy between
BP and FA, but previous studies in this population provide a
likely candidate: selectin genes.2,5,6 The region harboring the
constellation of selectin genes (SELP, SELL, and SELE) has
been identified as a region of significant linkage (LOD3.82)
between PP and HWM volume. In particular, the adhesion
molecule P-selectin34 is a marker of potential endothelial
dysfunction that has been implicated as a risk factor in
essential hypertension35,36 and stroke.35,37 Increased blood
levels of P-selectin have been implicated in formation of
atherosclerotic plaque, loss of vascular reactivity, and in-
crease in arterial pulsativity and SBP.35,37 In addition, plate-
let-derived gene expression levels of SELP were shown to be
strongly and positively correlated with arterial BP.38,39
Limitations
Our data indicate that a genotype-by-age interaction is poten-
tially responsible for genetic overlap between BP and FA.
Hence, it may be useful to explicitly allow for the potential
influences of genotype by age interactions. Although ad-
vanced statistical genetic methods for family-based data
allow for the formal detection of such interactions within
cross-sectional data, longitudinal family studies will have
much greater power to localize and ultimately identify the
specific genes involved in intersubject differences in the rates
of WM atrophy. Therefore, further research is needed to
confirm the cross-sectional trends observed here using a
longitudinal design.
A potential limitation of this study is that the collection of
BP measurements preceded the acquisition of brain images
by 3.00.8 (maximum 5.3) years. Individual subjects could
have experienced a rise in BP during the period between BP
and brain assessment, suggesting caution when interpreting
these findings.
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118.7±12.5 68.4±7.7 50.3±10.9 10 3 1 0 1 3 1 3 4 
30-39 76 
(35/41) 
117.9±13.0 72.2±9.2 45.6±9.9 32 8 3 0 3 18 3 8 18 
40-49 84 
(30/54) 
118.9±13.3 72.5±9.7 46.4±9.6 35 20 3 1 13 18 6 6 25 
50-59 80 
(28/52) 
125.4±17.5 72.9±10.5 52.5±13.0 29 27 5 3 15 31 12 4 34 
60-69 40 
(14/26) 
135.0±17.9 73.1±13.5 61.8±16.7 17 24 7 4 18 30 12 4 13 
70-79 25 
(12/13) 
131.1±16.4 71.0±13.3 60.2±16.4 10 14 3 4 13 17 10 1 5 
Table S1. Subjects’ demographic and health information including systolic (SBP), diastolic (DBP) and pulse pressure (PP), the 
number of obese subjects (body mass index>30), the number of subjects with hypercholesterolemia (total cholesterol levels > 200 
mg/dl) and hyperlipidemia (blood lipids>150 mg/dL), the number of subjects diagnosed with coronary heart disorder, diabetes, 
hypertension, the number of subjects taking antihypertensive medications, the number of subjects with alcohol dependence (AD)  and 







Figure S1. Scatter plots for whole-brain average FA values and results of linear regression, from top to bottom, for pulse pressure (PP) 
(FA=-0.001*PP + 0.56; r2=0.20); systolic blood pressure (SBP) (FA=-0.0006*SBP+0.58;r2=0.11) and diastolic blood pressure (DBP) 
(FA=1E-6*SBP+0.51; r2=0.0) 
